It’s March Madness, the Breast Friends Madness way!

In Episode 3, Dr. Jason Mouabbi and Dr. Paolo Tarantino are hitting the court to break down the heavy hitters of 2025 using our "Breast Friends Madness" bracket.

Among the featured lineups are studies ranging from the practice-changing results of the DESTINY-Breast trials to the strategic shifts in SERENA-6, monarchE, and ASCENT-04. We’re scouting the data officially rewriting the playbook for HER2+, TNBC, and HR+ care.

EVERY study in this bracket is a WIN for our patients. Let’s get ready to highlight the trials moving the field forward.

👉 Cast your vote here: tinyurl.com/breastfriendsmadness

▶️ Watch on YouTube

🎧 Listen on Spotify, Apple Podcasts, iHeartRadio, CastBox & Amazon Music

#BreastCancer #Oncology #OncologyPodcast #CancerResearch #ClinicalTrials #HER2Positive #TripleNegativeBreastCancer #MedEd #MedicalOncology

What’s coming in 2026 is about to reshape breast oncology.

In Episode 2, Dr. Jason Mouabbi and Dr. Paolo Tarantino go beyond published data to tackle the tough questions about what's next. They break down the evolving landscape of KEYNOTE-756, the rise of oral SERDs in the first line, and the role of HER2DX. From T-DXd in early disease and CNS risk in HER2+, to the promise of improving outcomes in triple-negative breast cancer, they are laying out the roadmap for the future of care.

The landscape is moving fast. Listen in as we prepare for the next wave of practice-changing data.

▶️ Watch on YouTube - https://youtu.be/Skt3jGMBncM

🎧 Listen on Spotify, Apple Podcasts, iHeartRadio, CastBox, & Amazon Music

#BreastCancer #Oncology #OncologyPodcast #ClinicalTrials #CancerResearch #HER2Positive #TripleNegative #OralSERD #ADCs #MedicalOncology #MedEd #CancerCare

It’s finally here. 🎙️

The first full episode of The Breast Friends Podcast is live. Join Dr. Jason A. Mouabbi and Dr. Paolo Tarantino for a comprehensive look at the rapidly evolving breast cancer landscape. From new endocrine backbones to the "unprecedented" data emerging in the ADC space, they are debating the breakthroughs that are changing the way we practice medicine today.

Beyond the statistics, this episode focuses on the "art" of clinical selection. You’ll hear an honest discussion on therapy sequencing, balancing toxicities, and navigating complex trial data—all while ensuring treatment is tailored to each patient’s unique needs and daily reality.

Real data. Hard questions. And yes—plenty of fun along the way.

#BreastCancer #OncologyPodcast #CancerCare #MedicalOncology #BreastCancerResearch #MedEd #ClinicalOncology #PhysicianVoices